Targeting composite treatment of type 2 diabetes in middle-income countries – walking a tightrope between hyperglycaemia and the dangers of hypoglycaemia
- Resource Type
- Authors
- J. R. Wing; Daksha Jivan
- Source
- South African Medical Journal; Vol 106, No 1 (2016); 57-61
SAMJ: South African Medical Journal, Volume: 106, Issue: 1, Pages: 57-61, Published: JAN 2016
- Subject
- medicine.medical_specialty
endocrine system diseases
Cost-Benefit Analysis
Developing country
Context (language use)
Type 2 diabetes
Hypoglycemia
Cost of Illness
Risk Factors
Internal medicine
Diabetes mellitus
medicine
Humans
Intensive care medicine
Developing Countries
Health policy
Poverty
business.industry
Health Policy
Type 2 Diabetes Mellitus
nutritional and metabolic diseases
General Medicine
medicine.disease
Endocrinology
Diabetes Mellitus, Type 2
Hyperglycemia
Income
business
Delivery of Health Care
- Language
- English
- ISSN
- 2078-5135
0256-9574
Middle-income countries need a rational and cost-effective approach to optimise management of type 2 diabetes mellitus (T2DM). There is a paucity of data from such countries on the extent of hypoglycaemia and its consequences for their healthcare systems. This review provides the context for health policy change and evaluates available data on diabetes complications, focusing on hypoglycaemia in T2DM patients in non-Western countries. Suitable guidelines are suggested for these communities, which are in transition from poverty to affluence and in transition from an environment where infectious diseases predominate to one where non-communicable diseases are predominant.